POLB — Poolbeg Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- £17.78m
- £9.95m
Annual cashflow statement for Poolbeg Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -2.34 | -4.78 | -4.5 | -5.94 |
| Amortisation | ||||
| Non-Cash Items | 0.24 | 0.22 | -0.131 | 0.454 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.068 | 0.163 | 0.229 | 0.73 |
| Change in Accounts Receivable | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -2.15 | -4.37 | -4.38 | -4.65 |
| Capital Expenditures | -0.081 | -0.597 | -0.175 | -0.129 |
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | — | 0.209 | 0.534 | 0.428 |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.081 | -0.388 | 0.359 | 0.299 |
| Financing Cash Flow Items | — | — | 0 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 23.2 | 0 | 0 | 0 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 20.9 | -4.76 | -4.02 | -4.35 |